Özet:

This study was planned to investigate the effectiveness of low-intensity laser therapy (DYL) in the treatment of clinical symptoms of primary fibromyalgia syndrome (FMS) patients and in the improvement of quality of life. 60 patients with Primary FMS were randomly divided into two groups: active gallium-arsenide (GaAs) laser (30 patients) and plasebo laser (30 patients). All patients were assessed in terms of the number of sensitive points, pain, morning hardness, sleep disorder, fatigue, muscle spasm, subjective swelling feeling and the rate of healing in paresthesia. The quality of life was assessed according to the Fibromyalgia Effect Survey (FIQ). Patients in the active laser group, at each point for 2 minutes, 4.4 J/cm2 Ga-As laser treatment was applied for 10 days. For the treatment of plasebo, the same device was used again without the spread of laser radiation. Results: After the treatment, healing has been statically significant in all parameters in both groups. CONTRACT AND RESULT: The results we obtain suggest that the application of DYL in the treatment of FMS is effective and that emotional factors play an important role in etiopatogenesis.

Anahtar Kelimeler: